Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature

[1]  D. Kaya,et al.  Reader response: Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry , 2020 .

[2]  C. Oppenheim,et al.  Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study , 2020 .

[3]  M. Gomez-Beldarrain,et al.  Neurological reasons for consultation and hospitalization during the COVID-19 pandemic , 2020, Neurological Sciences.

[4]  F. Roser,et al.  Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke , 2020, American Journal of Neuroradiology.

[5]  P. Striano,et al.  Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients , 2020, Neurological Sciences.

[6]  B. Cucchiara,et al.  Acute Cerebrovascular Events in Hospitalized COVID-19 Patients , 2020, Stroke.

[7]  C. Oppenheim,et al.  Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study. , 2020, Neurology.

[8]  S. Lehéricy,et al.  Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations , 2020, Radiology.

[9]  P. Gil,et al.  Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department , 2020, European Geriatric Medicine.

[10]  A. Ahmadzadeh,et al.  Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19 , 2020, Neurological Sciences.

[11]  Marika M. Cusick,et al.  Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. , 2020, JAMA neurology.

[12]  S. Paybast,et al.  Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection , 2020, The neurologist.

[13]  Ö. Karadaş,et al.  A prospective clinical study of detailed neurological manifestations in patients with COVID-19 , 2020, Neurological Sciences.

[14]  P. Matthews,et al.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study , 2020, The Lancet Psychiatry.

[15]  L. Tatu,et al.  Guillain–Barré syndrome in the COVID-19 era: another occasional cluster? , 2020, Journal of Neurology.

[16]  Josemir W Sander,et al.  New onset neurologic events in people with COVID-19 in 3 regions in China , 2020, Neurology.

[17]  Imen Megdiche,et al.  Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study , 2020, Radiology.

[18]  Vasuki H. Dandu,et al.  Spectrum of neuropsychiatric manifestations in COVID-19 , 2020, Brain, Behavior, and Immunity.

[19]  Deepak L. Bhatt,et al.  Prevalence and Outcomes of Acute Ischemic Stroke Among Patients ≤50 Years of Age With Laboratory Confirmed COVID-19 Infection , 2020, The American Journal of Cardiology.

[20]  B. Jacobs,et al.  Guillain–Barré syndrome after SARS‐CoV‐2 infection , 2020, European journal of neurology.

[21]  Pardis C Sabeti,et al.  Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.

[22]  T. Segura,et al.  Neurologic manifestations in hospitalized patients with COVID-19 , 2020, Neurology.

[23]  M. Leonardi,et al.  Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy , 2020, Neurology.

[24]  L. Saba,et al.  Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study , 2020, Radiology.

[25]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.

[26]  Simon A. Jones,et al.  COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome , 2020, Journal of the Neurological Sciences.

[27]  F. Journé,et al.  Objective olfactory evaluation of self‐reported loss of smell in a case series of 86 COVID‐19 patients , 2020, Head & neck.

[28]  S. Farmer,et al.  Characteristics of ischaemic stroke associated with COVID-19 , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[29]  Thomas J Oxley,et al.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young , 2020, The New England journal of medicine.

[30]  J. Masjuán,et al.  Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study , 2020, European journal of neurology.

[31]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.

[32]  Josemir W Sander,et al.  New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study , 2020, Epilepsia.

[33]  J. Benito-León,et al.  Miller Fisher syndrome and polyneuritis cranialis in COVID-19 , 2020, Neurology.

[34]  F. Cheng,et al.  Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China , 2020, Clinical Microbiology and Infection.

[35]  A. Green,et al.  The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines. , 2020, JAMA neurology.

[36]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[37]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[38]  J. M. Abduljalil,et al.  Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view , 2020, New microbes and new infections.

[39]  J. M. Abduljali,et al.  Epidemiology, genome and clinical features of the pandemic SARS-CoV-2: a recent view , 2020, New Microbes and New Infections.

[40]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[41]  A. Nath.  Neurologic complications of coronavirus infections , 2020, Neurology.

[42]  Dengju Li,et al.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.

[43]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[44]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[45]  Lanjuan Li,et al.  Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  Lanjuan Li,et al.  Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms , 2020, Gut.

[47]  Y. Xiong,et al.  Clinical features and treatment of COVID‐19 patients in northeast Chongqing , 2020, Journal of medical virology.

[48]  Wei Liu,et al.  Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study , 2020, Chinese medical journal.

[49]  Rui-guang Zhang,et al.  Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  Usman Ali,et al.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms , 2020, ACS chemical neuroscience.

[51]  Yuxin Shi,et al.  Clinical progression of patients with COVID-19 in Shanghai, China , 2020, Journal of Infection.

[52]  Y. Xian,et al.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study , 2020, Stroke and vascular neurology.

[53]  P. Espinosa,et al.  Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy , 2020, Cureus.

[54]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[55]  Shengqing Wan,et al.  Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations , 2020, Cell Discovery.

[56]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[57]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[59]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[60]  M. Ciccozzi,et al.  The 2019‐new coronavirus epidemic: Evidence for virus evolution , 2020, bioRxiv.

[61]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[62]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[63]  Daishi Tian,et al.  Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China , 2020 .

[64]  N. Gupta,et al.  The stimulation of thrombosis by hypoxia. , 2019, Thrombosis research.

[65]  M. Weigand,et al.  Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study , 2019, Annals of Intensive Care.

[66]  S. Marsch,et al.  Acute Neurologic Complications During Extracorporeal Membrane Oxygenation: A Systematic Review , 2018, Critical care medicine.

[67]  D. Cabrera,et al.  Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle , 2015, Medicinal research reviews.

[68]  A. Hajeer,et al.  Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) , 2015, Infection.

[69]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[70]  M. Moghadami,et al.  The Neurological Manifestations of H1N1 Influenza Infection; Diagnostic Challenges and Recommendations , 2011, Iranian journal of medical sciences.

[71]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[72]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[73]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[74]  L. Tsai,et al.  Neuromuscular disorders in severe acute respiratory syndrome. , 2004, Archives of neurology.

[75]  J. Sung,et al.  Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome , 2003, Clinical chemistry.